← Leaderboards
Jimmy D. Ballard
University Of Oklahoma Hlth Sciences Ctr
$17,910,925
Attributed
$17,910,925
Total exposure
20
Grants
18
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.8M · FY2007–25$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$31,202,073 · 21
By mechanism
P20$17,336,540 · 6
U19$7,222,454 · 10
R01$5,647,520 · 2
R21$988,559 · 2
R13$7,000 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Oklahoma Hlth Sciences Ctr
Same institution · by research overlap
- Maureen Cox$1,767,580
- Jason Larabee$715,000
- Lauren A Zenewicz$2,435,419
Others in their field
Top investigators on “Toxin”
- Jacqueline Moline · Icahn School Of Medicine At Mount Sinai$75,762,106
- Rosalind J Wright · Icahn School Of Medicine At Mount Sinai$75,392,927
- Alessandro Sette · La Jolla Institute For Immunology$39,651,711
- Milan Tomic · Xoma Corporation$38,826,613
- Jon Mirsalis · Sri International$38,701,962
- Robert H Vonderheide · University Of Pennsylvania$33,448,494
Research focus
ToxinInfectionProgramsMolecularPathogenInsightPathogenesisCellsVirulence FactorsResearch PersonnelBacterial ToxinsImmune ResponsePreventBacillus AnthracisAnthrax DiseaseClostridium DifficileReportingPublishingOklahomaIntoxicationEventPilot ProjectsImmunologicsVirulence
Grant awards (69)
Oklahoma Center for Microbial Pathogenesis and Immunity$2,153,497
P20 · FY2025 · GM · contact PI
Administrative Core$509,616
P20 · FY2025 · GM · contact PI
Enhancing C. difficile vaccination in the context of TcdB-mediated immunosuppression.$349,351
U19 · FY2025 · AI · contact PI
TBD$271,373
P20 · FY2025 · GM · contact PI
Oklahoma C. difficile U19 Challenge Core$76,269
U19 · FY2025 · AI · contact PI
Oklahoma Center for Microbial Pathogenesis and Immunity$2,149,632
P20 · FY2024 · GM · contact PI
Oklahoma CMP&I Administrative Core$550,326
P20 · FY2024 · GM · contact PI
Differential Effects of TcdB1 and TcdB2 in C. difficile disease$432,300
R01 · FY2024 · AI · contact PI
Enhancing C. difficile vaccination in the context of TcdB-mediated immunosuppression.$375,372
U19 · FY2024 · AI · contact PI
Oklahoma C. difficile U19 Challenge Core$85,438
U19 · FY2024 · AI · contact PI
Oklahoma Center for Microbial Pathogenesis and Immunity$2,157,378
P20 · FY2023 · GM · contact PI
Oklahoma CMP&I Administrative Core$558,691
P20 · FY2023 · GM · contact PI
Differential Effects of TcdB1 and TcdB2 in C. difficile disease$432,300
R01 · FY2023 · AI · contact PI
Enhancing C. difficile vaccination in the context of TcdB-mediated immunosuppression.$356,107
U19 · FY2023 · AI · contact PI
Oklahoma C. difficile U19 Challenge Core$73,231
U19 · FY2023 · AI · contact PI
Oklahoma Center for Microbial Pathogenesis and Immunity$2,166,688
P20 · FY2022 · GM · contact PI
Oklahoma CMP&I Administrative Core$583,534
P20 · FY2022 · GM · contact PI
Differential Effects of TcdB1 and TcdB2 in C. difficile disease$432,300
R01 · FY2022 · AI · contact PI
Oklahoma Center for Microbial Pathogenesis and Immunity$2,179,888
P20 · FY2021 · GM · contact PI
Oklahoma CMP&I Administrative Core$640,178
P20 · FY2021 · GM · contact PI
Differential Effects of TcdB1 and TcdB2 in C. difficile disease$432,300
R01 · FY2021 · AI · contact PI
Oklahoma Center for Microbial Pathogenesis and Immunity$2,484,065
P20 · FY2020 · GM · contact PI
Oklahoma CMP&I Administrative Core$604,716
P20 · FY2020 · GM · contact PI
Differential Effects of TcdB1 and TcdB2 in C. difficile disease$432,300
R01 · FY2020 · AI · contact PI
Microbiology and Immunology Training Laboratory$326,958
P20 · FY2020 · GM · contact PI
Differential Effects of TcdB1 and TcdB2 in C. difficile disease$370,000
R01 · FY2019 · AI · contact PI
Differential Effects of TcdB1 and TcdB2 in C. difficile disease$370,000
R01 · FY2018 · AI · contact PI
Toxin-Mediated Suppression of Human PBMC Responses During Bacteremia$325,600
U19 · FY2018 · AI · contact PI
Pilot Project Program$161,400
U19 · FY2018 · AI · contact PI
Differential Effects of TcdB1 and TcdB2 in C. difficile disease$370,000
R01 · FY2017 · AI · contact PI
Toxin-Mediated Suppression of Human PBMC Responses During Bacteremia$327,120
U19 · FY2017 · AI · contact PI
Pilot Project Program$210,914
U19 · FY2017 · AI · contact PI
Characterization of a C. difficile Toxin-Encoded Cell Penetrating Peptide$185,000
R21 · FY2017 · AI · contact PI
Toxin-Mediated Suppression of Human PBMC Responses During Bacteremia$481,246
U19 · FY2016 · AI · contact PI
Differential Effects of TcdB1 and TcdB2 in C. difficile disease$370,000
R01 · FY2016 · AI · contact PI
Characterization of a C. difficile Toxin-Encoded Cell Penetrating Peptide$222,000
R21 · FY2016 · AI · contact PI
Pilot Project Program$147,802
U19 · FY2016 · AI · contact PI
Toxin-Mediated Suppression of Human PBMC Responses During Bacteremia$325,600
U19 · FY2015 · AI · contact PI
Pilot Project Program$207,793
U19 · FY2015 · AI · contact PI
Differential Effects of TcdB1 and TcdB2 in C. difficile disease$185,000
R01 · FY2015 · AI · contact PI
Meeting on the Pathogenesis of Clostridia$7,000
R13 · FY2015 · AI · contact PI
Toxin-Mediated Suppression of Human PBMC Responses During Bacteremia$484,781
U19 · FY2014 · AI · contact PI
Pilot Project Program$148,889
U19 · FY2014 · AI · contact PI
Edema Toxin Suppression of Immune Responses During Anthrax Disease$365,813
U19 · FY2013 · AI · contact PI
Pilot Project Program$228,970
U19 · FY2013 · AI · contact PI
Scientific Core: Bacillus anthracis Anthrax Toxin Core$74,745
U19 · FY2013 · AI · contact PI
Edema Toxin Suppression of Immune Responses During Anthrax Disease$332,555
U19 · FY2012 · AI · contact PI
Pilot Project Program$142,591
U19 · FY2012 · AI · contact PI
Scientific Core: Bacillus anthracis Anthrax Toxin Core$83,802
U19 · FY2012 · AI · contact PI
Systemic events in Clostridium difficile associated disease$364,204
R01 · FY2011 · HL · contact PI
Edema Toxin Suppression of Immune Responses During Anthrax Disease$329,204
U19 · FY2011 · AI · contact PI
Pilot Project Program$163,241
U19 · FY2011 · AI · contact PI
Scientific Core: Bacillus anthracis Anthrax Toxin Core$117,903
U19 · FY2011 · AI · contact PI
Systemic events in Clostridium difficile associated disease$364,204
R01 · FY2010 · HL · contact PI
Edema Toxin Suppression of Immune Responses During Anthrax Disease$346,693
U19 · FY2010 · AI · contact PI
Pilot Project Program$151,573
U19 · FY2010 · AI · contact PI
Scientific Core: Bacillus anthracis Anthrax Toxin Core$124,202
U19 · FY2010 · AI · contact PI
Systemic events in Clostridium difficile associated disease$364,204
R01 · FY2009 · HL · contact PI
Edema Toxin Suppression of Immune Responses During Anthrax Disease$344,122
U19 · FY2009 · AI · contact PI
Pilot Project Program$153,438
U19 · FY2009 · AI · contact PI
Scientific Core: Bacillus anthracis Anthrax Toxin Core$126,689
U19 · FY2009 · AI · contact PI
Systemic events in Clostridium difficile associated disease$364,204
R01 · FY2008 · HL · contact PI
Systemic events in Clostridium difficile associated disease$364,204
R01 · FY2007 · HL · contact PI
The Impact of Anthrax Toxin on Embryonic Development$290,954
R21 · FY2004 · HD
Impact of Anthrax Toxin on Embryonic Development$290,605
R21 · FY2003 · HD
FUNCTIONAL GENOMIC/PROTEOMIC ANALYSIS OF B ANTHRACIS$0
P20 · FY2002 · RR
FUNCTIONAL GENOMIC/PROTEOMIC ANALYSIS OF B ANTHRACIS$0
P20 · FY2001 · RR
FUNCTIONAL GENOMIC/PROTEOMIC ANALYSIS OF B ANTHRACIS$0
P20 · FY2001 · RR
FUNCTIONAL GENOMIC/PROTEOMIC ANALYSIS OF B ANTHRACIS$0
P20 · FY2000 · RR